Weinhoff Gregory M
Insider CIK 1400975 · AXON Principal Financial Officer · CNTA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 123,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 31,002 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 230,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 584,321 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 100,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 319,660 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 125,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer | 2026-06-24 | 2026-06-24 | 65,925 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2026-03-26 | 2026-03-26 | 23,998 | — | $0 | 31,002 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2026-03-26 | 2026-03-26 | 23,998 | $3.85 | $92.4K | 89,923 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-26 | 2026-03-26 | 23,998 | $30.00 | $719.9K | 65,925 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-13 | 2026-03-13 | 61,253 | $26.17 | $1.60M | 77,868 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2026-03-13 | 2026-03-13 | 11,943 | $27.16 | $324.4K | 65,925 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2026-02-02 | 2026-02-03 | 123,000 | — | $0 | 123,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2026-02-02 | 2026-02-03 | 31,000 | — | $0 | 139,121 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2026-02-01 | 2026-02-03 | 14,158 | $24.57 | $347.9K | 108,121 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-07-25 | 2025-07-25 | 10,000 | — | $0 | 55,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-07-25 | 2025-07-25 | 10,000 | $3.85 | $38.5K | 132,279 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-07-25 | 2025-07-25 | 10,000 | $15.56 | $155.6K | 122,279 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-06-25 | 2025-06-25 | 10,000 | — | $0 | 65,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-06-25 | 2025-06-25 | 10,000 | $3.85 | $38.5K | 132,279 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-06-25 | 2025-06-25 | 10,000 | $13.86 | $138.6K | 122,279 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-05-27 | 2025-05-27 | 10,000 | — | $0 | 75,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-05-27 | 2025-05-27 | 10,000 | $12.82 | $128.2K | 122,279 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-05-27 | 2025-05-27 | 10,000 | $3.85 | $38.5K | 132,279 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-04-25 | 2025-04-25 | 11,742 | $13.61 | $159.8K | 122,279 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-03-25 | 2025-03-26 | 10,000 | — | $0 | 85,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-03-25 | 2025-03-26 | 10,000 | $3.85 | $38.5K | 144,021 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-03-25 | 2025-03-26 | 10,000 | $16.34 | $163.4K | 134,021 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-02-25 | 2025-02-26 | 11,494 | $15.25 | $175.3K | 134,021 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2025-02-03 | 2025-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2025-02-01 | 2025-02-04 | 14,267 | $16.92 | $241.4K | 145,515 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-01-27 | 2025-01-28 | 11,742 | $16.47 | $193.4K | 159,782 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-12-31 | 2024-12-31 | 11,742 | $16.35 | $192.0K | 171,524 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-12-26 | 2024-12-26 | 10,000 | — | $0 | 95,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-12-26 | 2024-12-26 | 10,000 | $3.85 | $38.5K | 193,266 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-12-26 | 2024-12-26 | 10,000 | $17.04 | $170.4K | 183,266 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-11-25 | 2024-11-27 | 10,000 | — | $0 | 105,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-11-25 | 2024-11-27 | 10,000 | $3.85 | $38.5K | 193,266 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-11-25 | 2024-11-27 | 10,000 | $17.66 | $176.6K | 183,266 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-10-25 | 2024-10-25 | 11,742 | $15.38 | $180.6K | 183,266 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-09-30 | 2024-10-02 | 11,742 | $15.79 | $185.4K | 195,008 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-09-25 | 2024-09-27 | 16,619 | $15.69 | $260.8K | 206,750 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-09-10 | 2024-09-12 | 30,000 | — | $0 | 584,321 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-09-10 | 2024-09-12 | 30,000 | $17.00 | $510.0K | 223,369 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-09-10 | 2024-09-12 | 30,000 | $5.84 | $175.2K | 253,369 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-09-09 | 2024-09-09 | 25,000 | — | $0 | 614,321 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-09-09 | 2024-09-09 | 25,000 | $15.00 | $375.0K | 223,369 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-09-09 | 2024-09-09 | 25,000 | $5.84 | $146.0K | 248,369 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-08-23 | 2024-08-23 | 17,802 | $12.29 | $218.8K | 223,369 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-08-22 | 2024-08-23 | 12,198 | $12.17 | $148.4K | 241,171 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-06-30 | 2024-07-02 | 11,742 | $9.03 | $106.0K | 253,369 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-03-31 | 2024-04-02 | 11,742 | $11.30 | $132.7K | 265,111 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2024-02-01 | 2024-02-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-02-01 | 2024-02-02 | 11,494 | $8.19 | $94.1K | 276,853 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2024-02-01 | 2024-02-02 | 31,250 | — | $0 | 288,347 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-12-31 | 2024-01-02 | 11,742 | $7.96 | $93.5K | 257,097 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-09-30 | 2023-10-03 | 11,742 | $6.47 | $76.0K | 268,839 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-06-30 | 2023-07-03 | 11,742 | $5.90 | $69.3K | 280,581 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-03-31 | 2023-04-04 | 8,292 | $3.90 | $32.3K | 292,323 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2023-02-01 | 2023-02-03 | 115,000 | — | $0 | 115,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2023-02-01 | 2023-02-03 | 77,200 | — | $0 | 300,615 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2022-12-31 | 2023-01-04 | 5,303 | $3.10 | $16.4K | 234,697 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2022-10-03 | 2022-10-04 | 4,901 | $3.95 | $19.4K | 231,099 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2022-09-30 | 2023-01-13 | 11,282 | $4.25 | $47.9K | 228,718 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2022-09-30 | 2022-10-04 | 4,000 | $4.07 | $16.3K | 236,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2022-07-01 | 2022-07-06 | 230,000 | — | $0 | 240,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2022-02-01 | 2022-02-03 | 230,000 | — | $0 | 230,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2021-06-02 | 2021-06-04 | 10,000 | $20.00 | $200.0K | 10,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | G Gift deriv | 2021-04-08 | 2021-06-04 | 319,660 | — | $0 | 319,660 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | G Gift deriv | 2021-04-08 | 2021-06-04 | 319,660 | — | $0 | 639,321 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2021-03-04 | 2021-06-04 | 958,981 | — | $0 | 958,981 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2018-03-15 | 2018-03-16 | 450,000 | — | $0 | 450,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2018-03-15 | 2018-03-16 | 700,000 | — | $0 | 700,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2017-04-28 | 2017-05-02 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2016-04-29 | 2016-05-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2015-09-15 | 2015-09-17 | 454,096 | — | $0 | 454,096 | SEC↗ |